HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Undisclosed Allergen, Caffeine Claims Prompt Supplement Recalls

This article was originally published in The Rose Sheet

Executive Summary

Firms marketing supplements found to contain steroid ingredients also are recalling products.

You may also be interested in...



Chicago Supplement Firm Runs Out Of Chances To Correct GMP, Label Violations

"Despite repeated promises to fix the problems, Defendants have not done so. Accordingly, the United States now seeks a permanent injunction to bring Defendants’ operations into compliance with the law," US attorneys say in a complaint. Global Marketing Enterprises enters consent decree with FDA requiring that before resuming manufacturing and distributing supplements, it implement remedial measures to brings its operations into compliance.

FDA Flexes Warnings For Steroid Ingredients On Supplement Labels

Warning letters state that ingredients listed on labels for AndroPharm and Hardcore Formulations brand products "are synthetic steroids and do not constitute dietary ingredients" under FDA regulations.

FDA Takes The Measure Of Bulk Caffeine In Warnings About Labels

Serving amounts such as one-sixteenth of a teaspoon indicated on product labels “cannot be accurately measured using common household measuring tools,” FDA says. NPA, however, suggests the agency gives too little credit to consumers’ measuring skills.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel